Skip to content

PDVT

Active Private limited companyfounded 2023active for 3 yearsKolomstraat 1, 1080 Molenbeek-Saint-JeanKBO/BCE: BE 0803.065.968

Overview

Lifetime

2 annual accounts with figures on one time axis
peak €45,382 (2024)
€35,353▼ 22.1%
peak €32,012 (2024)
€23,659▼ 26.1%
peak €60,671 (2025)
€60,671▲ 63.9%
€31,194▼ 6.8%
Board1 name since 2023
Documentsfilings and deeds
03-03-2026150 days before the deadline
2025micro format
Gross margin from €45,382 to €35,353Result from €32,012 to €23,659Registered office moved from Pont-à-Celles to Brussels 18-11Equity from €37,012 to €60,671

Key points

from the 2025 annual accounts

Turnover

≈ €140,000 estimated

The micro format states no turnover.

Liquidity

2.94 was 2.11 in 2024

Short-term debts fell from €33,457 to €31,194.

Checked score

96
Excellent
Financially stronger than 78% of micro companies in research and development (NACE 72)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

The dashed line is the sector median: 0.1% across 932 companies (NACE 72, micro).

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 12-2024: 0.9% 01-2025: 0.9%● unchanged vs 12-2024 02-2025: 1.0%▲ +0.1 percentage points vs 01-2025 03-2025: 1.0%● unchanged vs 02-2025 04-2025: 1.0%● unchanged vs 03-2025 05-2025: 1.1%▲ +0.1 percentage points vs 04-2025highest value 06-2025: 0.1%▼ -1.0 percentage point vs 05-2025lowest value 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026 11-2026: 0.1%● unchanged vs 10-2026

Financial strength
Strong

91+13equity 66.0% of total assets
85+8short-term debt 34.0% · cash 89.3%
100=return on assets 25.8%

Score breakdown

raises risk
1 change of registered office in 24 months
lowers risk
Liquidity: current ratio 2.94, cash €82,032
Sector: Scientific research and development (NACE 72)
Equity €60,671 (66.0% of total assets)
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, micro). It does better than 58% of them on solvency, 74% on liquidity, 90% on profitability and 89% on growth.

The bankruptcy probability was computed on 10-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 31-12-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Comparable companies, two years later

In July 2024, 39,278 companies had the same profile as PDVT has now. Each dot stands for 99 companies, two years later.

95.8%
were still trading
2.3%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

The bankruptcy probability of PDVT itself is lower: 0.1% within 12 months. It rests on far more data about PDVT than the profile alone.

Test of the method

The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,278 companies, not a prediction for PDVT. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit of up to €5,000 on 30-day terms is acceptable

Liquidity is ample, with a current ratio of 2.94 (2.11 in 2024), above the usual 1.5. Short-term debt is 34% and cash 89.3% of total assets. 34% of the assets are financed with debt and provisions.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Liquidity: current ratio 2.94, cash €82,032
NBB · annual accounts
lowers risk · Sector: Scientific research and development (NACE 72)
KBO
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
lowers risk · Equity €60,671 (66.0% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 03-03-2026, 150 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
150 days early
2024
87 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 2 accounts on average 119 days before the deadline. In the sector (NACE 72), the median for financial year 2024 was 13 days before the deadline, and 32% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
11-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2023.
KBO publications

Board and ownership

  • Paula Diaz Vidal all the sharesdeed of 18-11-2025
Board & ownership

Recent changes

Registered office moved from Pont-à-Celles to Brussels New registered office: Rue de la Colonne 1A, 1080 Bruxelles · Previous registered office: Rue Saint-Antoine 2, 6230 Pont-à-Celles · Paula Diaz Vidal holds all the shares · General meeting of 14-09-2025 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0803065968
Incorporation Founding capital of €5,000, 100 shares · Founder: DIAZ VIDAL Paula Andrea (comparante) · Appointment: DIAZ VIDAL Paula Andrea (director) · published on 26-06-2023 · Gazette deed
First establishment Avenue Paul Pastur 424, Charleroi
All 6 events

Comparable companies

same main activity, similar in size and age
Company
PDVT Molenbeek-Saint-Jean €91,865 €35,353 66.0% -
ZAIENCE Boom €81,571 €48,947 39.7% -
IDA INTERNATIONAL Leuven €101,921 €23,415 25.6% -
1991 Southern Sky Anderlecht €77,620 €32,062 3.5% -
Epitech Research Auderghem €132,574 €59,658 87.0% -
DEDAL Ixelles €139,276 €73,605 70.7% -
Aquature Technologies Antwerp €122,734 €43,790 52.1% 0.3

These companies have the same main activity as PDVT: research and development on biotechnology (NACE 72101). They are comparable in size and age: total assets between €77,600 and €139,000, founded between 2022 and 2023.

Official details

Source: KBO
Status
Active since 22-06-2023Normal situation
Registered office
135 active companies are registered at this address7 started in the 12 months before. Source: KBO register, as of 10 November 2026.
Activity
Research and development on biotechnologyNACE 72101
Establishment unit
2.346.431.6816032 Charleroi, since 22-06-2023
Financial year end
31 December
Peppol
Reachable since 12-11-2024
Company details

Annual accounts 2025

€35,353▼ 22.1%
€23,659▼ 26.1%
€60,671▲ 63.9%
€91,865▲ 30.4%
Filing
Filed on 03-03-2026, 150 days before the end of the filing period
Financials

Insights on PDVT

PDVT has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €60,671 and a net result of €23,659.

Its solvency ranks better than 55% of 620 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Sources: KBO register, filings at the National Bank, Belgian Official Gazette.

Financials

Annual accounts 2025

micro format, filed on 03-03-2026, 150 days before the deadline
€35,353
▼ 22.1%
€32,551
▼ 23.2%
€23,659
▼ 26.1%
€60,671
▲ 63.9%
66.0%
▲ 13.5 percentage points
2.94
▲ 0.84

Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.

Turnover ≈ €140,000. Estimated: probably between €85,000 and €260,000.

Balance sheet

balance sheet total €91,865 on 31-12-2025
What the company ownsHow it is paid for

in euro

in euro

Position in the sector

66.0%

Higher than 55% of 620 companies in 2025.

2.94

Higher than 53% of 580 companies in 2025.

25.8%

Higher than 76% of 597 companies in 2025.

PDVT Middle half of the sector 80% of the sector Micro accounts in research and development (NACE 72)

Net result: middle half · Equity: middle half · Balance sheet total: bottom quarter · Working capital: middle half

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend20252024
Balance sheet: assets
20/58 91,86570,469
29/58 91,86570,469
40/41 9,8331,914
40 6,207-
41 3,6261,914
54/58 82,03268,555
Balance sheet: equity and liabilities
10/49 91,86570,469
10/15 60,67137,012
10/11 5,0005,000
14 55,67132,012
17/49 31,19433,457
42/48 31,19433,457
42 22,16618,000
44 3,034-
440/4 3,034-
45 5,34915,457
450/3 5,34915,457
47/48 645-
Income statement
9900 35,35345,382
62 -347
640/8 2,8022,647
9901 32,55142,388
75/76B -1
75 -1
65/66B 1,3251,078
65 1,3251,078
9903 31,22641,311
67/77 7,5679,299
9904 23,65932,012
9905 23,65932,012
Appropriation of the result
9906 55,67132,012
14P 32,012-
Document PDFPDF

The notes to these accounts have 1 item. You find them in the filed accounts (PDF).

Source: Annual accounts 2025 (PDF), filed on 03-03-2026.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
31-12-2025 micro format 03-03-2026 2026-00051117 PDF
31-12-2024 micro format 05-05-2025 2025-00090696 PDF

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend20252024
13,477-
60,67137,012
66.0%52.5%
2.942.11
0.510.90
39.0%86.5%
25.8%45.4%

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Insights on PDVT

The operating result for 2025 is 23% lower than in 2024.

Debt's share of the balance-sheet total falls from 47.5% to 34.0%. Equity is higher and debt is lower.

Board & ownership

Board

1 director, since incorporation
Director
appointed by deed of 26-06-2023 term without a fixed end

Office holders in the KBO →

Mandates through the years

1 name, the dashed line is today
Board
Mandates as a list
  • DIAZ VIDAL Paula Andrea
    • Director, appointed by deed of 26-06-2023, still in office

See the board, name and registered office on a given date →

Control

Shareholder
Paula Diaz Vidal
This company
PDVT
Equity €60,671
Profit €23,659 in 2025

Capital

Contribution
€5,000
Shares
100
Contribution per share
€50
Equity per share
€607 in 2025
Source
deed of 26-06-2023

Articles of association

deed of 26-06-2023 (in French)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Board ruleThese rules set how the board is made up, meets and takes decisions.
At least 1 director

Shareholders

Stated in the deed deed of 18-11-2025 ↗
  • Paula Diaz Vidal all shares
At incorporation deed of 26-06-2023 ↗

Network & group

No group

PDVT has no parent and no holdings in its annual accounts. DIAZ VIDAL Paula Andrea is the only director. PDVT shares no director with another company.

At the same address

Kolomstraat 1, 1080 Molenbeek-Saint-Jean · 134 other companies
one2three
registered office since 14-06-2013 · founded in 2013 · group TRIPL
6.9 FTE (2025)
0535.701.405
ALEO FINANCES INTERNATIONAL
registered office since 19-02-2015 · founded in 2015 · accounts filed late
total assets €631,541 (2024)
0598.822.273
Mark & Jhony Concept
registered office since 26-05-2014 · founded in 2013 · accounts filed late
turnover €624,045 (2024)
0542.795.370
PIXITE PRODUCT MANAGEMENT
establishment since 06-11-2020 · founded in 2020
turnover €148,874 (2025)
0757.883.566
SO TRANS
registered office since 01-02-2019 · founded in 2019
total assets €573,027 (2025)
0719.730.003
PERIFERIA
registered office since 01-01-2008 · founded in 1999
5.6 FTE (2025)
0464.986.920
AXE ADVISORY
registered office since 28-03-2023 · founded in 2023
turnover €506,730 (2023)
0800.059.958
GING
registered office since 07-12-2021 · founded in 2021 · accounts filed late
turnover €380,552 (2023)
0778.341.361
N4V1
registered office since 07-03-2022 · founded in 2022
total assets €303,433 (2025)
0782.938.369
HR TRANSPORT
registered office since 01-08-2023 · founded in 2023
total assets €290,457 (2024)
0804.473.062
and 124 more

Timeline

Timeline

6 events since 2023

Deadline for the 2026 accounts: 31-07-2027

2026
Annual accounts 2025 filed PDFmicro format · 150 days before the deadline
2025
Registered office moved from Pont-à-Celles to BrusselsNew registered office: Rue de la Colonne 1A, 1080 Bruxelles · Previous registered office: Rue Saint-Antoine 2, 6230 Pont-à-Celles · Paula Diaz Vidal holds all the shares · General meeting of 14-09-20253 points ▸
  • General meeting, 14-09-2025
  • Paula Diaz Vidal holds all the shares
  • Registered-office move, Rue de la Colonne 1A, 1080 Bruxelles
  • The deed holds 4 more points.

Open the deed in the Belgian Official Gazette

Annual accounts 2024 filed PDFmicro format · 87 days before the deadline
2024
Registered in the Peppol Directory Reachable for e-invoices through 0208:0803065968
2023
IncorporationFounding capital of €5,000, 100 shares · Founder: DIAZ VIDAL Paula Andrea (comparante) · Appointment: DIAZ VIDAL Paula Andrea (director) · published on 26-06-20235 points ▸
  • Founder, DIAZ VIDAL Paula Andrea (comparante)
  • Founding capital, €5,000, 100 shares
  • Registered office clause, rue Saint Antoine numéro 2, 6230 Pont-à-Celles
  • Board rule, 1
  • Director appointment, DIAZ VIDAL Paula Andrea
  • The deed holds 8 more points.

Open the deed in the Belgian Official Gazette

First establishment Avenue Paul Pastur 424, Charleroi

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

PDVT was incorporated on 22 June 2023 as a private limited company by one natural person, with a starting capital of €5,000.12 The registered office was moved to Brussels in 2025.3 DIAZ VIDAL Paula Andrea is director of the company, appointed by deed of 26-06-2023.2

  1. 1KBO register
  2. 2Belgian Official Gazette, 26-06-2023
  3. 3Belgian Official Gazette, 18-11-2025

Company details

Identity

Enterprise number
0803.065.968
VAT number
BE 0803.065.968
Peppol ID
0208:0803065968
Other Peppol ID
9925:BE0803065968
Legal form
Private limited company
Status
Active, normal situation
Founded
22-06-2023
Financial year
ends on 31 December
Peppol
Reachable since 12-11-2024Follow this company and you will hear the next morning if it leaves the Peppol register.
Name
PDVT in French
Entity type
Legal entity
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 26-06-2023 (in French)

Activities

NACEBEL 2025
Codes under NACEBEL 2008
72110 Scientific research and development main activity
PurposeThe purpose describes the activities the company may carry out under its articles.
“Le suivi de la recherche clinique; Œuvrer dans le domaine de la santé et de soutenir le développement des médicaments; Surveiller la…”
39 activities
  1. Le suivi de la recherche clinique.
  2. Œuvrer dans le domaine de la santé et de soutenir le développement des médicaments ;
  3. Surveiller la recherche clinique (notamment pharmaceutique) ;
  4. Préparer la soumission d’études cliniques auprès des autorités européennes
  5. Suivre la soumission d’études cliniques auprès des autorités européennes.
  6. Préparer des rapports sur les agents pharmaceutiques faisant l'objet d'une enquête ;
  7. Suivre, superviser, faire des rapports sur toutes les formes possibles d'essais cliniques ainsi que la cartographie statistique de ces études ;
  8. Diriger au sens le plus large des essais cliniques, y compris sous forme d'expériences, sur l'action des médicaments ;
  9. Surveiller, superviser, l'avancement des projets conformément au plan (délais et budget et collaborateurs) ;
  10. Délivrer le projet et/ou le programme dans les délais et le budget prévus ;
  11. Développer et rédiger le protocole de l'étude et fournir une contribution scientifique et opérationnelle.
  12. Développer et rédiger les budgets/ les contrats de l’étude clinique
  13. Collaborer et coordonner avec les partenaires pour suivre la création et les performances des outils d’encodage destiné à l’étude clinique ;
  14. Examiner la faisabilité du protocole ;
  15. Collaborer et coordonner avec les partenaires pour suivre les statistiques de performance et établir des rapports sur les données.
  16. Participation aux discussions scientifiques relatives à la conception et aux résultats de l'étude en vue de leur publication ;
  17. Conférences et publications.
  18. Réaliser des présentations lors de conférences.
  19. Fournir et organiser des cours, des séminaires, de l'éducation et de la formation.
  20. Publication d'ouvrages professionnels.
  21. Fournir des conseils de nature financière, technique, commerciale, juridique ou de nature administrative ; au sens large, à l'exclusion des conseils en matière d'investissements et de placements monétaires. les investissements et les placements d'argent.
  22. Fournir une assistance et des services, directement ou indirectement dans les domaines de l'administration et des finances, des ventes, de la production des ressources humaines et de la gestion générale
  23. Fournir toutes les prestations de services et réaliser toutes missions sous forme d'études
  24. D'organisation, d'expertises, d'actions techniques et de consultations ou autres dans tous les domaines.
  25. Activités de gestion, à savoir : assistance, conseil et orientation aux entreprises, aux particuliers et aux institutions, principalement mais non exclusivement dans le domaine de la santé.
  26. Entreprises, aux particuliers et aux institutions, principalement mais non exclusivement dans les domaines suivants ;gestion, du marketing, de la production et du développement, de la transformation et de l'administration des entreprises, au sens le plus large.
  27. Activités de gestion, à savoir : assistance, conseil et orientation aux entreprises, aux particuliers et aux institutions, principalement mais non exclusivement dans le domaine de la santé, de marketing, de la production ,du développement, de la transformation et de l'administration des entreprises, au sens le plus large.
  28. L'octroi de prêts et d'ouvertures de crédit aux entreprises ou aux particuliers, sous toute forme, dans ce contexte, elle peut également se porter garante ou donner son aval, au sens le plus large, à toutes les opérations commerciales et financières, à l'exception de celles qui sont prévues par la loi. Au sens large, effectuer toutes les opérations commerciales et financières, à l'exception de
  29. Celles qui sont légalement réservées aux banques de dépôt, aux détenteurs de dépôts à court terme et à la clientèle. Légalement réservées aux banques de dépôt, aux détenteurs de dépôts à court terme, aux caisses d'épargne, aux sociétés hypothécaires et aux sociétés de capitalisation.
  30. Acquérir et détenir des participations, sous quelque forme que ce soit, dans toutes les sociétés ou entreprises existantes ou à constituer. Encouragement, planification et coordination du développement des sociétés et entreprises dans lesquelles elle détient une participation. Participer à leur gestion, leur administration, leur liquidation et leur contrôle et fournir une assistance technique, administrative et financière à ces sociétés et entreprises.
  31. La société a pour objectif d'encourager, de planifier et de coordonner le développement bénéfique des entreprises auxquelles elle participe.
  32. La création, le développement judicieux et la gestion du patrimoine immobilier : toutes les opérations relatives aux biens immobiliers et aux droits réels immobiliers. toutes opérations portant
  33. Sur des immeubles et droits réels immobiliers, à quelque titre que ce soit de location, de construction et de bail, de lotissement, d'intermédiaire et, en général, toutes opérations qui, directement ou indirectement, se rapportent à la gestion ou à la mise en valeur d'immeubles ou de droits réels immobiliers.
  34. A cet effet, la société peut accomplir, pour son propre compte ou pour le compte de tiers, tous les actes mobiliers et immobiliers, financiers et commerciaux qui, directement ou indirectement, sont nécessaires à l'accomplissement de sa mission. actes mobiliers et immobiliers, financiers et commerciaux, qui, directement ou indirectement, se rapportent indirectement, en tout ou en partie, à l'objet social ou susceptibles d'en favoriser la réalisation ou
  35. Susceptibles de favoriser la réalisation de cet objet.
  36. La société sera donc autorisée à accomplir tous les actes sans exception nécessaires, utiles ou même simplement propices.
  37. La société peut réaliser son objet tant en Belgique qu'à l'étranger de la manière qu'elle jugera la plus appropriée.
  38. La société peut, par voie d'apport, de fusion ou de toute autre manière, participer à toutes les sociétés qui exercent une activité similaire, complémentaire ou connexe.
  39. Elle peut exercer les fonctions d’administrateur ou liquidateur dans d’autres sociétés.
deed of 26-06-2023 (in French)

Registered office and establishments

1 establishment
Establishment Since Unit number
Kolomstraat 1 registered office 1080 Molenbeek-Saint-Jean
Avenue Paul Pastur 424 6032 Charleroi 22-06-2023 2.346.431.681
1 former office
  • Rue Saint-Antoine 2, 6230 Pont-à-Celles until the deed of 18-11-2025

Buildings and parcels at the addresses

Ground area
291 m²
Buildings
141 m²
Volume, LiDAR
1,859 m³
Tallest building
17.3 m
Buildings to scale, each on its own parcel
86 m², 17.3 m 54 m², 13.1 m 86 m², 17.3 m 54 m², 13.1 m

Location

registered office establishment The establishment unit on the map
135 companies at this address See who is registered here

Parcels

Wallonia 1 (50%) Brussels 1 (50%)
Cadastral parcelRegionArea Buildings Height / floors
52050A0178/00W003Wallonia197 m² 1 · 54 m² 13.1 m · 4
21522B0621/00K000Brussels93 m² 1 · 86 m² 17.3 m · 5